Aug 07, 2019 Will Sangamo Therapeutics Continue to Surge Higher? | Nasdaq Mar 06, 2020 SGMO -- Is Its Stock Price A Worthy Investment? Learn More.
Sangamo Therapeutics, Inc. - SGMO - Stock Price Today - Zacks Get the latest Sangamo Therapeutics Inc SGMO detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Sangamo Therapeutics, Inc. - SGMO - Stock Price Today - Zacks SGMO is down today, All News for SGMO : Sangamo Therapeutics, Inc. - Zacks.com Implied Volatility Surging for Sangamo (SGMO) Stock Options by Zacks Equity Research Published on July 02,2019 Investors need to pay close attention to Sangamo (SGMO) stock based on the movements
Sangamo Therapeutics Inc (NASDAQ:SGMO) announced its earnings results on Monday, May, 11th. The biopharmaceutical company reported ($0.37) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.23) by $0.14. SGMO Stock Price | Sangamo Therapeutics Inc. Stock Quote ... SGMO | Complete Sangamo Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Sangamo Therapeutics, Inc. (SGMO) Stock Price, Quote ... Find the latest Sangamo Therapeutics, Inc. (SGMO) stock quote, history, news and other vital information to help you with your stock trading and investing.
Sangamo Therapeutics (SGMO) came out with a quarterly loss of $0.24 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to loss of $0.13 per share a year ago. These figures are adjusted for non-recurring items. Zacks: Analysts Expect Sangamo Therapeutics Inc (NASDAQ ... Zacks Investment Research upgraded Sangamo Therapeutics from a “hold” rating to a “strong-buy” rating and set a $9.50 price objective on the stock in a research note on Thursday, March 5th. HC Wainwright restated a “buy” rating and set a $16.00 price target on shares of Sangamo Therapeutics in a research report on Monday, March 2nd. Sangamo Therapeutics (NASDAQ:SGMO) Downgraded to Hold …
SGMO Sangamo Therapeutics, Inc. daily Stock Chart Zacks. 04:01PM. Sangamo Therapeutics Reports Business Highlights and First Quarter 2020 Financial (NASDAQ:SGMO) . The stock has moved higher by 6.2% in the past month, while it is Zacks Investment Research. Biotech